A Science|Business Healthy Measures & Data Rules Online Conference
DOWNLOAD THE REPORTS:
- Interact with us on Twitter @scibus and through #SBhealth
- Join the event's LinkedIn group for networking opportunities and more content: https://www.linkedin.com/groups/13878108/
Even before the emergence of COVID-19, the significance of real world data to European health policy and programmes was growing – notably in the domain of patient-reported outcomes and their integration into health system performance assessment frameworks, which inspired Science|Business to create its Healthy Measures initiative back in 2016.
Arguably, the current pandemic is highlighting how valuable these data will be in future, not only to healthcare but also to research & development and innovation. The realities of societal lockdowns have ushered digital technologies and solutions into the mainstream of health services, from telemedicine and virtual diagnostics to mobile apps and patient monitoring – surely a ‘new normal’ that will continue into the recovery phase and beyond.
Similarly, the unprecedented level of global R&D cooperation to fight the coronavirus is creating a vast data pool, shared across borders, to which a wide spectrum of artificial intelligence, high-performance computing and big data tools are being applied in pursuit of vaccines, treatments, containment and more. If used smartly, these resources will fuel years of scientific endeavour, both within Europe and internationally. And they may have a critical role to play in supporting industrial value chains and an economic recovery that delivers a greener, smarter future for all.
That said, there is much work still to be done to prepare for the era of real world data. According to OECD analysis, only two countries have the necessary infrastructure in place to manage real time health data flows – but the pandemic may catalyse a fundamental change in political mindsets and willingness to make this happen.
As such, a major opportunity landscape lies ahead for the European Commission and other R&D leaders. In this Science|Business webcast conference, we will explore the implications of real world, real time data for the anticipated European Health Data Space, a revitalised European Research Area, as well as other key digital policies such as the European approach to AI and data strategy.
10:00 - Welcome & introductions
Simon Pickard, Network Director, Science|Business
10:05 - Beyond COVID: Where next for European health?
- Policy perspectives from Andrzej Rys, Director for Health Systems, Medical Products and Innovation, DG SANTE, European Commission
- Patient perspectives from Lara Bloom, President & CEO, Ehlers-Danlos Society
Moderated by Simon Pickard, Network Director, Science|Business
10:30 - Better prepared: A new era for health policy and partnerships?
‘Fire side’ chat with:
- Didier Jourdan – Chairholder, Global Health & Education, UNESCO
- Tomislav Sokol, Member, European Parliament
Moderated by Maryline Fiaschi, Managing Director, Science|Business
11:00 - Paradigm shift: Real world data and smart, healthy futures
Panel discussion with:
- Minna Hendolin, Senior Director, Health and Wellbeing, Ecosystems, Business Finland
- Mark Pearson, Deputy-Director for Employment, Labour and Social Affairs, OECD
- Janneke van der Kamp, Head, Region Europe, Novartis
11:45 - Concluding remarks & break
12:00 - Chatroom Sessions – Interactive, moderated discussions (*by registration only)
Fresh fields: Real world data and transforming the status quo in:
1/ Health registries & data infrastructure
- Arild Faxvaag, Professor in Health Informatics, Norwegian University of Science and Technology (NTNU)
- Hans Juul Hedegaard, Head, Data Service Strategy, Danish Health Data Authority
Moderated by Simon Pickard, Network Director, Science|Business
2/ Clinical practice
- Theodoros Arvanitis, Chair, Digital Health Innovation & Director, Institute of Digital Healthcare, Warwick Manufacturing Group, University of Warwick
- Jordi Serrano Pons, GP, Founder & CEO, UniversalDoctor
Moderated by Ruben Díaz Naderi, Deputy CEO, International Affairs, Sant Joan de Déu Hospital, Barcelona
3/ Outcomes measurement in post-COVID health systems
- Monica Dietl, Advisor to the Director-General; Coordinator Action Plan Europe, DG R&I, French Ministry for Higher Education
- Douglas Gregory, Senior Director, Government Affairs Strategy & Excellence, Bristol Myers Squibb
Moderated by Elke Grooten, Head of Brussels Office, Novartis
4/ E-health: A new model for mental and physical care
- Lara Bloom, President & CEO, Ehlers-Danlos Society
- Levi Marelus, Co-Founder, Friendlybuzz Company
Moderated by Lysiane Pons, Project Manager, Science|Business
-----------------------------------------------------------
12:45 - Lunch break
-----------------------------------------------------------
14:00 - Welcome
Maryline Fiaschi, Managing Director, Science|Business
14:05 - Opening remarks – Patient data: A new driver for European science & technology?
Kaisa Immonen, Director of Policy, European Patients Forum
14:10 - Silver linings: Will COVID revitalise European research?
Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, European Commission
Moderated by Maryline Fiaschi, Managing Director, Science|Business
14:30 - Precious resources: What should Europe do with its COVID and health research data?
‘Fireside chat’ featuring:
- Mirit Eldor, Executive Vice President Strategy, Elsevier
- Xosé Fernandez, Chief Data Officer, Institut Curie
Moderated by Simon Pickard, Network Director, Science|Business
15:00 - Digital futures: Will AI and data transform post-crisis healthcare?
Panel discussion featuring:
- Jan-Philipp Beck, Chief Executive Officer, EIT Health
- Mateo Valero Cortes, Director, Barcelona Supercomputing Center
- Casper Klynge, Vice President Government Affairs, Microsoft
15:45 - Concluding remarks & Conference close
On June 30, if you wish to join a breakout session but haven't registered, please contact Andrea Stavrou ([email protected])
Partners
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
